About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
2021 Virtual Best of Breast
Videos
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
W
BC Risk Management: Should We Be Offering Testing to Everyone? Do We Have the Capacity to Do This?
By
2021 Virtual Best of Breast
FEATURING
Wendy K. Chung
,
Jennifer Klemp
,
Jane Meisel
,
Monica Yepes
By
2021 Virtual Best of Breast
FEATURING
Wendy K. Chung
,
Jennifer Klemp
,
Jane Meisel
,
Monica Yepes
84 views
February 5, 2021
0 Comments
Login to view comments.
Click here to Login
Videos
16:02
2021 Virtual Best of Breast
Case Study of Premenopausal Woman With HR+, HER2- MBC: What Does the…
Feat.
K. Hunt,
R. L. Mahtani,
E. Krill-Jackson,
M. Cusnir,
L. Hineman
08:26
2021 Virtual Best of Breast
HR+/HER2- MBC: What Are the Biopsy and 1L Treatment Options Using NC…
Feat.
K. Hunt,
R. L. Mahtani,
E. Krill-Jackson,
M. Cusnir,
L. Hineman
14:15
2021 Virtual Best of Breast
Breast Cancer Genetic Testing: What Are the Most Common Mutations? W…
Feat.
W. Chung,
J. Klemp,
J. Meisel,
M. Yepes
15:59
2021 Virtual Best of Breast
Optimizing Genetic Testing for BC: Who & When Should Get Tested?
Feat.
W. Chung,
J. Klemp,
J. Meisel,
M. Yepes
17:37
2021 Virtual Best of Breast
PARPi for BC With Germline Mutations: Why Are They Good Option for B…
Feat.
W. Chung,
J. Klemp,
J. Meisel,
M. Yepes
08:46
2021 Virtual Best of Breast
BC Risk Management: Should We Be Offering Testing to Everyone? Do We…
Feat.
W. Chung,
J. Klemp,
J. Meisel,
M. Yepes
13:34
2021 Virtual Best of Breast
BC Cascade Testing: How Can Patients Use Testing to Inform Their Fam…
Feat.
W. Chung,
J. Klemp,
J. Meisel,
M. Yepes
06:14
2021 Virtual Best of Breast
Combatting Endocrine Resistance in BC: Use of Integrated Medicine Ap…
Feat.
K. Hunt,
R. L. Mahtani,
E. Krill-Jackson,
M. Cusnir,
L. Hineman
19:31
2021 Virtual Best of Breast
Endocrine Decision Making in BC: OFS+Tamoxifen/Exemestane - What Pro…
Feat.
K. Hunt,
R. L. Mahtani,
E. Krill-Jackson,
M. Cusnir,
L. Hineman
06:18
2021 Virtual Best of Breast
40 y/o Premenopausal Woman With mBC: Does LRT for the IPT Show Survi…
Feat.
K. Hunt,
R. L. Mahtani,
E. Krill-Jackson,
M. Cusnir,
L. Hineman
09:19
2021 Virtual Best of Breast
BC Side Effects: What Are the Key Points That Need to Be Assessed at…
Feat.
J. Klemp,
K. Mirabeau-Beale,
K. Rojas,
M. Lima
07:34
2021 Virtual Best of Breast
Postmenopausal Woman With Triple-Positive Breast Cancer: How to Appr…
Feat.
J. Klemp,
K. Mirabeau-Beale,
K. Rojas,
M. Lima
22:46
2021 Virtual Best of Breast
56 y/o Postmenopausal Woman With Triple-Positive BC: Estrogen Depriv…
Feat.
J. Klemp,
K. Mirabeau-Beale,
K. Rojas,
M. Lima
10:46
2021 Virtual Best of Breast
BC Side Effects & Survivorship: What Are the Most Common AI-Rela…
Feat.
J. Klemp,
K. Mirabeau-Beale,
K. Rojas,
M. Lima
13:24
2021 Virtual Best of Breast
BC & Menopause Side Effects: Cardio-Toxicity, Cardiac Sparing Ra…
Feat.
J. Klemp,
K. Mirabeau-Beale,
K. Rojas,
M. Lima
06:12
2021 Virtual Best of Breast
BC Side Effects: Cost of Cancer Care - Determinants, Effects & B…
Feat.
J. Klemp,
K. Mirabeau-Beale,
K. Rojas,
M. Lima
12:07
2021 Virtual Best of Breast
40 y/o Premenopausal Woman With Palpable Right Breast Mass: Should W…
Feat.
K. Hunt,
R. L. Mahtani,
E. Krill-Jackson,
M. Cusnir,
L. Hineman
21:39
2021 Virtual Best of Breast
36 y/o Pre-Menopausal Woman With EBC: Is IDFS Better With ET Alone o…
Feat.
L. Freedman,
K. Kalinsky,
T. Mamounas,
L. Nye
21:08
2021 Virtual Best of Breast
36 y/o Pre-Menopausal Woman With EBC: Does PMRT After ALND Reduce th…
Feat.
L. Freedman,
K. Kalinsky,
T. Mamounas,
L. Nye
09:37
2021 Virtual Best of Breast
36 y/o Pre-Menopausal Woman With EBC: Does OFS+Exemestane Improve DR…
Feat.
L. Freedman,
K. Kalinsky,
T. Mamounas,
L. Nye
14:59
2021 Virtual Best of Breast
36 y/o Pre-Menopausal Woman With EBC: Can Tamoxifen Reduce Mortality…
Feat.
L. Freedman,
K. Kalinsky,
T. Mamounas,
L. Nye
21:20
2021 Virtual Best of Breast
55 y/o Woman With mTNBC: Genetic Counseling/Testing, Bilateral Breas…
Feat.
A. Amin,
E. Krill-Jackson,
K. Kalinsky,
M. Press
14:28
2021 Virtual Best of Breast
55 y/o Woman With mTNBC: Can We Achieve pCR With Pembro/Atezo? What …
Feat.
A. Amin,
E. Krill-Jackson,
K. Kalinsky,
M. Press
07:08
2021 Virtual Best of Breast
55 y/o Woman With mTNBC: What Is the FNR of SLN Surgery After Chemo?…
Feat.
A. Amin,
E. Krill-Jackson,
K. Kalinsky,
M. Press
03:22
2021 Virtual Best of Breast
55 y/o Woman With mTNBC: Does Adjuvant Capecitabine Improve DFS Afte…
Feat.
A. Amin,
E. Krill-Jackson,
K. Kalinsky,
M. Press
10:19
2021 Virtual Best of Breast
55 y/o Woman With mTNBC: Is Atezo+Nab-Paclitaxel Beneficial for PFS/…
Feat.
A. Amin,
E. Krill-Jackson,
K. Kalinsky,
M. Press
09:43
2021 Virtual Best of Breast
2021 Update on New Agents for mTNBC: ADCs (Sacituzumab Govitecan, La…
Feat.
A. Amin,
E. Krill-Jackson,
K. Kalinsky,
M. Press
09:00
2021 Virtual Best of Breast
59 y/o Woman With HER2+ Invasive Ductal Carcinoma: Is Neoadjuvant Tr…
Feat.
P. Anderson,
S. Badve,
E. Hamilton,
R. L. Mahtani
12:44
2021 Virtual Best of Breast
59 y/o Woman With HER2+ EBC: Should We Choose T-DM1 as Post-Neoadjuv…
Feat.
P. Anderson,
S. Badve,
E. Hamilton,
R. L. Mahtani
11:19
2021 Virtual Best of Breast
HER2+ mBC Case Study Discussion: PFS Data of Tucatinib + Trastuzumab…
Feat.
P. Anderson,
S. Badve,
E. Hamilton,
R. L. Mahtani
22:37
2021 Virtual Best of Breast
Case Study Discussion on HER2+ MBC: Trastuzumab Deruxtecan in Heavil…
Feat.
P. Anderson,
S. Badve,
E. Hamilton,
R. L. Mahtani
